Changes in concentrations of tau-reactive antibodies are dependent on sex in Alzheimer's disease patients

被引:10
作者
Krestova, Michala [1 ]
Ricny, Jan [1 ]
Bartos, Ales [1 ,2 ]
机构
[1] Natl Inst Mental Hlth, Topolova 748, Klecany 25067, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
关键词
Alzheimer's disease; Mild cognitive impairment; Antibody; Tau protein; Post-translational modification; Sex; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; NATURAL ANTIBODIES; INTRAVENOUS IMMUNOGLOBULIN; NEUROFIBRILLARY TANGLES; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DOUBLE-BLIND; SERUM;
D O I
10.1016/j.jneuroim.2018.05.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The presence of pre-existing natural antibodies against Alzheimer's disease (AD) pathological proteins might interfere with immune responses to therapeutic vaccination with these proteins. We aimed to compare levels of antibodies in CSF and serum: 1) against three various tau antigens 2) between AD patients, MCI and other dementias and cognitively normal individuals 3) to find out if the antibody levels are dependent on age and sex We observed higher reactivity of natural tau-reactive antibodies towards phosphorylated bovine tau protein than to human recombinant (non-phosphorylated) tau protein. Males with MCI-AD had higher amounts of these antibodies than corresponding controls. Concentrations of antibodies were lower in females with the MCI-AD than in control females. These findings may have implications for tau vaccination trials.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [41] Generalizability of tau and amyloid plasma biomarkers in Alzheimer's disease cohorts of diverse genetic ancestries
    Griswold, Anthony J.
    Rajabli, Farid
    Gu, Tianjie
    Arvizu, Jamie
    Golightly, Charles G.
    Whitehead, Patrice L.
    Hamilton-Nelson, Kara L.
    Adams, Larry D.
    Sanchez, Jose J.
    Mena, Pedro R.
    Starks, Takiyah D.
    Illanes-Manrique, Maryenela
    Silva, Concepcion
    Bush, William S.
    Cuccaro, Michael L.
    Vance, Jeffery M.
    Cornejo-Olivas, Mario R.
    Feliciano-Astacio, Briseida E.
    Byrd, Goldie S.
    Beecham, Gary W.
    Haines, Jonathan L.
    Pericak-Vance, Margaret A.
    ALZHEIMERS & DEMENTIA, 2025, 21 (03)
  • [42] Based on Tau PET Radiomics Analysis for the Classification of Alzheimer's Disease and Mild Cognitive Impairment
    Jiao, Fangyang
    Wang, Min
    Sun, Xiaoming
    Ju, Zizhao
    Lu, Jiaying
    Wang, Luyao
    Jiang, Jiehui
    Zuo, Chuantao
    BRAIN SCIENCES, 2023, 13 (02)
  • [43] Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer's disease
    Quattrini, Giulia
    Ferrari, Clarissa
    Pievani, Michela
    Geviti, Andrea
    Ribaldi, Federica
    Scheffler, Max
    Frisoni, Giovanni B.
    Garibotto, Valentina
    Marizzoni, Moira
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3265 - 3275
  • [44] Effects of Meditation on Structural Changes of the Brain in Patients With Mild Cognitive Impairment or Alzheimer's Disease Dementia
    Dwivedi, Madhukar
    Dubey, Neha
    Pansari, Aditya Jain
    Bapi, Raju Surampudi
    Das, Meghoranjani
    Guha, Maushumi
    Banerjee, Rahul
    Pramanick, Gobinda
    Basu, Jayanti
    Ghosh, Amitabha
    FRONTIERS IN HUMAN NEUROSCIENCE, 2021, 15
  • [45] Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
    Mattsson, Niklas
    Insel, Philip S.
    Palmqvist, Sebastian
    Portelius, Erik
    Zetterberg, Henrik
    Weiner, Michael
    Blennow, Kai
    Hansson, Oskar
    EMBO MOLECULAR MEDICINE, 2016, 8 (10) : 1184 - 1196
  • [46] Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
    Bejanin, Alexandre
    Schonhaut, Daniel R.
    La Joie, Renaud
    Kramer, Joel H.
    Baker, Suzanne L.
    Sosa, Natasha
    Ayakta, Nagehan
    Cantwell, Averill
    Janabi, Mustafa
    Lauriola, Mariella
    O'Neil, James P.
    Gorno-Tempini, Maria L.
    Miller, Zachary A.
    Rosen, Howard J.
    Miller, Bruce L.
    Jagust, William J.
    Rabinovici, Gil D.
    BRAIN, 2017, 140 : 3286 - 3300
  • [47] Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study
    Ma, Ling-Zhi
    Tan, Lan
    Bi, Yan-Lin
    Shen, Xue-Ning
    Xu, Wei
    Ma, Ya-Hui
    Li, Hong-Qi
    Dong, Qiang
    Yu, Jin-Tai
    MOLECULAR NEURODEGENERATION, 2020, 15 (01)
  • [48] Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease
    Sjodin, Simon
    Brinkmalm, Gunnar
    Ohrfelt, Annika
    Parnetti, Lucilla
    Paciotti, Silvia
    Hansson, Oskar
    Hardy, John
    Blennow, Kaj
    Zetterberg, Henrik
    Brinkmalm, Ann
    ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (01)
  • [49] Sex differences in the structural rich-club connectivity in patients with Alzheimer's disease
    Kim, Soo-Jong
    Bae, Youn Jung
    Park, Yu Hyun
    Jang, Hyemin
    Kim, Jun Pyo
    Seo, Sang Won
    Seong, Joon-Kyung
    Kim, Geon Ha
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [50] Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review
    Canevelli, Marco
    Ancidoni, Antonio
    Valletta, Martina
    Blasi, Marco Toccaceli
    Alfano, Alba Rosa
    Buscarnera, Simona
    Salzillo, Martina
    Nuti, Filippo
    Zambri, Francesca
    Di Nolfi, Annachiara
    Lacorte, Eleonora
    Grande, Giulia
    Vanacore, Nicola
    Bruno, Giuseppe
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 102 (03) : 587 - 596